Your institution may have access to this item. Find your institution then sign in to continue.
Title
Pioglitazone: potential bladder cancer.
Abstract
The article reports on a 2010 decision which the U.S. Food and Drug Administration made to review data from an ongoing, ten year epidemiological study designed to evaluate whether the drug pioglitazone is associated with an increased risk of bladder cancer.